Top Markets
Coin of the day
Adynxx, Inc. Adynxx, Inc.

Adynxx, Inc.

ADYX
Clasificación en acciones #42632
Adynxx, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating... Adynxx, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating and commercializing novel transcription factor decoy technologies to combat pain and inflammatory conditions. Central to its efforts is the AYX platform of transcription factor decoys, which includes brivoligide, currently progressing through Phase II clinical development for reducing post-surgical discomfort. Additionally, AYX2 is a pre-clinical candidate being explored for its potential in treating localized chronic pain. Established in 2007, the company's corporate headquarters are situated in San Francisco, California.
Precio por acción
$0.0001
Última sincronización: 2026-08-11
Capitalización bursátil
$581.00
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Adynxx, Inc. (ADYX)

Categoría

Historial del precio de la acción de Adynxx, Inc. (ADYX)
Precio más alto de cierre: $0.00 el 2026-08-01

Precio más bajo de cierre: $176.75 el 1998-12-01
Historial del precio de la acción de Adynxx, Inc. desde 1998 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 0.00%
2025 5.44%
2024 -9.43%
2023 -16.00%
2022 -98.67%
2021 -95.38%
2020 -82.63%
2019 -91.35%
2018 7.40%
2017 -67.79%
2016 -71.93%
2015 -48.93%
2014 -38.71%
2013 222.40%
2012 -31.95%
2011 -49.51%
2010 -10.76%
2009 1.67%
2008 -66.17%
2007 -18.69%
2006 -63.01%
2005 -60.31%
2004 29.59%
2003 2,783.48%
2002 52.14%
2001 29.87%
2000 -64.49%
1999 125.40%
1998 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$527.87 36.13%
US
$873.57 37.02%
NL
$736.38 8.73%
CH
$263.09 20.45%
BE
$1.07K -5.56%
KR